ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627371; 2) Community: the network communities that were significantly associated with the response to NSC 627371; 3) Molecule: the relationships between components within communities and NSC 627371; 4) MDR: the compounds that were significantly associated with the NSC 627371.

NSC Compound Enrichment Correlation
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0461160768969335 0.39451504
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0461160768969335 0.28153407
NSC 36758 Null 0.0461160768969335 0.47865687
NSC 373355 Saframycin R 0.0461160768969335 0.42697622
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0461160768969335 0.15031169
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0461160768969335 0.28674999
NSC 44585 9H-Purin-2-amine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9-(2-methylpropyl)- (9CI) 0.0461160768969335 0.52221756
NSC 48229 Null 0.0461160768969335 -0.34610029
NSC 48300 ANTINEOPLASTIC-48300 0.0461160768969335 0.54048733
NSC 529108 4-Fluoro-D,L-tryptophan 0.0461160768969335 0.23050562
Total:113  Current:107    [First] [Prev] [Next] [Last]